A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina

Cardiology

Volumn 96, Issue 2, 2001, Pages 72-77

  Hall, Roger ^a   Chong, Camilla ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Amlodipine; Efficacy; Elderly patients; Isosorbide mononitrate; Once daily treatment; Safety; Stable angina

Indexed keywords

AMLODIPINE; GLYCERYL TRINITRATE; ISOSORBIDE 5 NITRATE; ISOSORBIDE MONONITRATE;

AGED; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EXERCISE TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; AMLODIPINE; ANGINA PECTORIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; EDEMA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEADACHE; HEART RATE; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NITROGLYCERIN; QUALITY OF LIFE; TIME FACTORS; VASODILATOR AGENTS;

EID: 0035217109     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047392     Document Type: Article

References (24)

1. Choosing the most appropriate treatment for stable angina: Safety considerations
2. Coronary vascular reactivity and calcium antagonist therapy in patients with angina
3. A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris
4. The pharmacokinetic profile of amlodipine
5. Amlodipine once a day in stable angina: Double-blind crossover comparison with placebo
6. Haemodynamic and electrophysiological effects of amlodipine, a new long-acting calcium antagonist
7. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease
8. Clinical safety and efficacy of once daily amlodipine for chronic stable angina pectoris
9. The efficacy of amlodipine in myocardial ischemia
10. A review of amlodipine in myocardial ischaemia
11. A double-blind dose-response study of amlodipine in patients with stable angina pectoris
12. Amlodipine and the total ischemic burden: Circadian Anti-Ischemia Program in Europe (CAPE) trial - Methodology, safety and toleration
13. Amlodipine in chronic stable angina: Results of a multicenter double-blind crossover trial
14. Clinical evaluation of serum amlodipine level in patients with angina pectoris
15. Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group
16. Amlodipine versus slow release metoprolol in the treatment of stable exertional angina pectoris (AMSA)
17. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris
18. Calcium channel blockers and mortality in elderly patients with myocardial infarction
19. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia
20. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring
21. Combination of calcium channel blockers and β-adrenoceptor blockers for patients with exercise-induced angina pectoris: A double-blind parallel-group comparison of different classes of calcium channel blockers
22. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: Beneficial effect of calcium channel blockers largely determined by their effect on heart rate
23. Use of drugs with more than a twenty-four-hour duration of action
24. Patient compliance and therapeutic coverage: Amlodipine versus nifedipine (slow-release) in the treatment of angina pectoris